How is the legislative amendment that allows for VAT adjustment in relation to contributions paid in the pharmaceutical field applied in practice?

It has been a year since the Fiscal Code was amended by Law no. 33/2024 to allow companies to reduce the VAT tax base and with price discounts that are not granted directly to customers in the sales chain, but which have the effect of reducing the price paid by the final consumer. The amendment also targeted quarterly contributions paid in the pharmaceutical field (i.e. "clawback" and cost-volume) or co-payment discounts, which have the effect of reducing the final price paid by patients for medicines.

For more information, please see the Romanian version of the article, here.